JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
National Institute of Arthritis and Musculoskeletal and Skin Diseases · National Institutes of Health · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,177
total citations
- FWCI
- 25.45
- Percentile
- 100%
- References
- 185
Citations per year
Authors
5- SBShubhasree BanerjeeCorresponding
National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health
- ABAnn Biehl
National Institutes of Health Clinical Center
- MGMassimo Gadina
National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health
- SHSarfaraz Hasni
National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases
- DMDaniella M. Schwartz
National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Topics & keywords
Topics
Keywords
- Tofacitinib
- Medicine
- Janus kinase
- Immunology
- stat
- Rheumatoid arthritis
- JAK-STAT signaling pathway
- Autoimmunity
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.